During the past decade, Novant Health Cancer Institute Radiation Oncology - Wilmington conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Novant Health Cancer Institute Radiation Oncology - Wilmington" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Novant Health Cancer Institute Radiation Oncology - Wilmington" are "Prostate Adenocarcinoma" (3 trials), "Metastatic Malignant Neoplasm in the Bone" (2 trials), "Anatomic Stage IV Breast Cancer AJCC v8" (1 trials), "Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8" (1 trials) and "Basaloid Squamous Cell Carcinoma" (1 trials). Many other conditions were trialed in "Novant Health Cancer Institute Radiation Oncology - Wilmington" in a lesser frequency.

Most popular intervention types in "Novant Health Cancer Institute Radiation Oncology - Wilmington" are "Radiation" (7 trials), "Drug" (4 trials), "Other" (4 trials), "Procedure" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Questionnaire Administration" (4 trials), "Quality-of-Life Assessment" (3 trials), "Bicalutamide" (2 trials), "Buserelin" (2 trials) and "Degarelix" (2 trials). Other intervention names were less common.

The vast majority of trials in "Novant Health Cancer Institute Radiation Oncology - Wilmington" are 4 trials for "Male" genders, 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Novant Health Cancer Institute Radiation Oncology - Wilmington". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Novant Health Cancer Institute Radiation Oncology - Wilmington, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Novant Health Cancer Institute Radiation Oncology - Wilmington, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".